Fresita Proteins Ltd has announced a rights issue of 74.8 lakh shares at Rs 120 per share to raise Rs 89.76 crore. The proceeds will fund investments in subsidiaries Urja Protein India and Fresita Food. Promoters will not participate to meet SEBI's minimum public shareholding requirements.
Fresita Proteins Announces Rs 89.76 Crore Rights Issue
Issue Size: Rs 89.76 crore; Price: Rs 120 per share.
Reader Takeaway: Rights issue fuels subsidiary growth while promoter non-participation ensures SEBI public float compliance for the company.
What just happened
Fresita Proteins Ltd is launching a rights issue of up to 74,79,917 fully paid-up equity shares. The issue is priced at Rs 120 per share, which includes a premium of Rs 110. The company will offer 5 rights shares for every 6 shares held by eligible shareholders as of the record date, October 30, 2026. The subscription window is set for November 12, 2026, through November 26, 2026.
Why this matters
The capital raise of Rs 89.76 crore is primarily earmarked for inorganic growth. Specifically, Rs 70 crore will be invested into its subsidiaries, Urja Protein India Private Limited and Fresita Food Private Limited. The remaining Rs 18.76 crore is allocated for general corporate purposes. This investment is intended to scale the company's operational footprint through these entities.
The backstory
The company currently faces a regulatory requirement to adhere to Minimum Public Shareholding (MPS) norms set by SEBI. With promoters holding 80.66% of the equity, they have formally decided to forgo their rights entitlements. This strategic non-participation is intended to dilute the promoter stake and increase the public float, thereby aligning the company with exchange listing regulations.
Financial Snapshot
For the quarter ending June 30, 2026, the company posted a total income of Rs 12.99 crore with a net profit of Rs 1.66 crore. In the preceding fiscal year ending March 31, 2026, the company reported total income of Rs 16.51 crore and a net profit of Rs 0.45 crore.
What to track next
Shareholders should monitor the successful integration of the subsidiaries receiving the funds. Additionally, investors must ensure that all application procedures, including the mandatory ASBA process, are completed by the November 26, 2026 deadline.
